Sugemalimab approval in China makes it only second drug approved globally for ENKTL: GlobalData Read more
Vertex Pharma poised to dominate global gene therapy market with first CRISPR approval: GlobalData Read more
Verve’s gene-editing therapy trial to lower cholesterol levels opens doors for use in CVDs: GlobalData Read more
First-in-class DLL3-targeting BiTE could be the next big player in SCLC treatment: GlobalData Read more
Zydus NCE drugs will see improved market penetration with new partnerships in India: GlobalData Read more
Novel therapies to drive Crohn’s disease market growth across 8MM to $15 bn by 2032: GlobalData Read more